EyePoint Pharmaceuticals
EYPT
EYPT
36 hedge funds and large institutions have $13.5M invested in EyePoint Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
14% less funds holding
Funds holding: 42 → 36 (-6)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Holders
36
Holding in Top 10
–
Calls
$36K
Puts
$10K
Top Buyers
| 1 | +$195K | |
| 2 | +$186K | |
| 3 | +$96.4K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66.9K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$53K |
Top Sellers
| 1 | -$1.54M | |
| 2 | -$225K | |
| 3 | -$172K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$55K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$39K |